13 NASDAQ Stocks with Highest Dividends

Page 7 of 7

6. Amgen Inc. (NASDAQ:AMGN)

Dividend Yield as of April 12: 2.87%

On April 10, Morgan Stanley analyst Terence Flynn raised the firm’s price recommendation on Amgen Inc. (NASDAQ:AMGN) to $326 from $309. It reiterated an Equal Weight rating on the shares. The firm updated its models across biopharma coverage, reflecting IQVIA trends and intra-quarter changes ahead of Q1 earnings.

On April 8, Truist also boosted its price goal on Amgen to $325 from $319 and maintained a Hold rating. The update came as part of a broader preview of Q1 earnings across the biotech sector. The firm said that reactions to regulatory and policy shifts have started to ease. It also pointed to a recent pickup in deal activity, which it believes could carry momentum through the rest of the year and into the mid-term period. For Amgen specifically, Truist raised its longer-term penetration assumptions for Krystexxa, reflecting stronger patent protection through 2040. It also increased the probability of success for MariTide, citing improved confidence in its commercial potential in obesity.

Amgen Inc. (NASDAQ:AMGN) is a biotechnology company focused on developing treatments for serious diseases. It works on discovering, developing, manufacturing, and delivering medicines, with a focus on areas of high unmet medical need. The company operates within the human therapeutics segment.

While we acknowledge the potential of AMGN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMGN and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 NASDAQ Stocks with Highest Dividends

Disclosure: None. Follow Insider Monkey on Google News.

Page 7 of 7